Business Description
Electra Therapeutics is a South San Francisco-based biotech company founded in 2018 that focuses on developing new medicines for cancer and immune system disorders. Its lead drug candidate, ELA026, works by attaching to specific proteins on the surface of certain immune cells and eliminating the harmful ones that drive dangerous inflammatory conditions. The company is currently pursuing this approach as a potential treatment for secondary hemophagocytic lymphohistiocytosis, a rare and life-threatening condition caused by an overactive immune response.
